← Back to Search

Behavioral Intervention

PRISM Intervention for Breast Cancer (PRISM Trial)

N/A

Recruiting

Led By Gabrielle Rocque, MD, MSPH

Research Sponsored by University of Alabama at Birmingham

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Women undergoing neoadjuvant chemotherapy with early-stage breast cancer

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 5 years

Awards & highlights

PRISM Trial Summary

This trial tests a program called PRISM that helps people, particularly adolescents and young adults with cancer, to build resilience through coaching sessions focused on stress management, goal-setting, and positive thinking. Previous studies

Who is the study for?

This trial is for women receiving initial chemotherapy for early-stage breast cancer or treatment for metastatic breast cancer. It aims to help those who may benefit from building resilience and managing stress during their cancer journey, including marginalized communities.Check my eligibility

What is being tested?

The PRISM program is being tested, which involves skills-based coaching to improve resilience through stress management, goal-setting, and positive reframing. The intervention has shown promise in other settings and will be tailored for adult women with breast cancer.See study design

What are the potential side effects?

Since PRISM focuses on psychological support rather than medication, traditional side effects are not a concern. However, participants might experience emotional discomfort as they engage with the intervention's activities.

PRISM Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am a woman receiving initial chemotherapy for early-stage breast cancer.

PRISM Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 5 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~5 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Promoting Resilience in Women with Breast Cancer

PRISM Trial Design

1Treatment groups

Experimental Treatment

Group I: PRISM InterventionExperimental Treatment1 Intervention

This single-arm pilot study will (1) test feasibility, acceptability, and appropriateness of the PRISM intervention in individuals with breast cancer, (2) elicit patient perspectives on elements for future adaptation or expansion to meet the unique needs of women with breast cancer, (3) assess trajectory of patient-reported outcomes and biological measures of stress for patients with breast cancer receiving the PRISM intervention.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of Alabama at BirminghamLead Sponsor

1,590 Previous Clinical Trials

2,281,422 Total Patients Enrolled

31 Trials studying Breast Cancer

4,451 Patients Enrolled for Breast Cancer

Gabrielle Rocque, MD, MSPHPrincipal InvestigatorThe University of Alabama at Birmingham

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the collective count of individuals actively involved in this research trial?

"Indeed, the information on clinicaltrials.gov indicates that this investigation is currently enrolling participants. The trial was initially listed on January 24th, 2024, and last modified on February 22nd, 2024. They aim to recruit a total of 40 patients from one designated site."

Answered by AI

Are new patients still eligible to participate in this ongoing clinical trial?

"Indeed, data from clinicaltrials.gov indicates that this investigation is actively seeking participants. The trial was first listed on January 24th, 2024 and last revised on February 22nd, 2024. It aims to recruit a total of 40 patients from one designated site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Promoting Resilience in Women With Breast Cancer

Gabrielle Rocque 2024. "Promoting Resilience in Women With Breast Cancer". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06133348.

All > Womens Health